PH receives 1.1M Pfizer vaccine doses procured through ADB loan | Inquirer News
Close  

PH receives 1.1M Pfizer vaccine doses procured through ADB loan

/ 09:50 PM December 23, 2021

PEDIATRIC DOSE A vial of the BioNtech-Pfizer vaccine Comirnaty is for kids. —AFP

MANILA, Philippines — About 1.1 million more Pfizer COVID-19 vaccine doses arrived in the Philippines on Thursday, procured by the government through a loan from the Asian Development Bank (ADB).

The National Task Force Against COVID-19 said that some 1,187,550 vaccine doses arrived via Air Hong Kong flight LD456, which touched down at the Ninoy Aquino International Airport Terminal 3 around 8 p.m.

ADVERTISEMENT

With this delivery, the Philippines received a total of 2,730,780 Pfizer anti-COVID shots this day, as 1,543,230 doses were already transported in the morning.

Of the around 192 million various COVID-19 vaccines that have arrived in the country since February, 104 million have already been administered.

FEATURED STORIES

As of December 22, some 46.3 million individuals in the country are fully vaccinated against COVID-19.

The Philippines is targeting to fully immunize 54 million Filipinos by year end to achieve population protection.

EDV

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.
Read Next
Don't miss out on the latest news and information.

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Asian development bank, coronavirus vaccines, NTF against COVID-19, Pfizer
For feedback, complaints, or inquiries, contact us.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and
acknowledge that I have read the Privacy Policy.



© Copyright 1997-2022 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.